For millions suffering from chronic inflammatory diseases like inflammatory bowel disease (IBD), managing flare-ups often involves powerful drugs with significant side effects. A new study published in National Science Review…
Researchers have found in a new study that flowable short fiber–reinforced resin composite demonstrated significantly higher fracture resistance under both monotonic static loading and repeated subcritical stress. Its consistently superior…
USA: A randomized clinical trial published in JAMA Internal Medicine suggests that a collaborative care model adapted for low-resource primary care settings does not provide additional benefit over enhanced usual…
Vinoth Thangamani et al conducted a study to assess the radiological, clinical, and neurological outcome of patients who had thoracolumbar burst fractures and had undergone short-segment posterior stabilization with single-index…
Cipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.
A new study published in the journal of BMC Women’s Health showed that uterine fibroids (UF) may shrink if vitamin D supplements and animal-based forms of vitamin A are consumed.…
A new study published in the journal of JID Innovations revealed that pemphigus is not significantly associated with an increased risk of most psychiatric disorders when compared to matched controls,…
China: Researchers have found in a new meta-analysis that mepolizumab is an effective and safe treatment for severe eosinophilic asthma, leading to improved lung function, fewer exacerbations, and better asthma…
And other biotech news, brought to you by The Readout newsletter
Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more than $1 billion